The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
about
The divergent roles of macrophages in solid organ transplantationABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugsProteasome inhibitor bortezomib ameliorates intestinal injury in mice.NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.Inhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice.Global intron retention mediated gene regulation during CD4+ T cell activation.Opposing effects on immune function and skin barrier regulation by the proteasome inhibitor bortezomib in an allergen-induced eczema model.Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib.Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification.The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytesCharacterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.Different effects of bortezomib on the expressions of various protein kinase C isoenzymes in T cells of patients with systemic lupus erythematosus and in Jurkat cells.Proteolytic activity and expression of the 20S proteasome are increased in psoriasis lesional skin.
P2860
Q27022711-501A287D-AC15-45B3-B096-F5303FF04FC5Q28545799-DF9C1475-40E8-4AE8-8474-9B6AF78A1BD1Q34222685-DDF85C8E-5191-45A1-A2F2-7BF238BF7310Q36110806-1BBB385C-DFE9-4AE5-88BD-4096FDF5369BQ36217025-F0CCED0D-038A-437A-885B-E8678D3FBB25Q37211030-3A02C7A0-B118-499A-B688-B806DC00C00DQ43806219-7155BC12-03CC-4B74-860B-EF9E8112735FQ43923033-F5546DCE-4944-4DEA-B999-A53DE7162D4AQ47115512-37E42CB3-776C-4FAF-A5E5-B33711985632Q47122756-DDE86AB1-1408-4E9D-9D82-4CDADC4A8FBFQ51642518-38F925B2-33B4-4A86-80F5-1D7737ACB7D0Q53497512-614F2962-CA0A-4059-AB45-5D8D6FCEB362Q53975226-C20E2D59-A731-4541-9ED8-B2881FCB7281Q54360544-47CBC2BB-95D7-4DAA-821A-0EB285BEF73A
P2860
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@en
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@nl
type
label
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@en
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@nl
prefLabel
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@en
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@nl
P2093
P2860
P356
P1476
The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.
@en
P2093
Ayumi Yoshizaki
Eiji Muroi
Fumihide Ogawa
Kazuhiro Shimizu
Koichi Yanaba
Shinichi Sato
Toshihide Hara
P2860
P304
P356
10.1189/JLB.1009666
P577
2010-04-23T00:00:00Z